Titiimaea Alailima

This inventor holds 13 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 2 EPO patents. Top assignee: Akili Interactive Labs, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Titiimaea Alailima. Retrieved from https://idiyas.com/inventor/titiimaea-alailima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

Cambridge, MA (US) (2022 - 2024)
Boston, MA (US) (2023 - 2024)

Company Filing History:

13 out of 29

Akili Interactive Labs, Inc.

patents

Years Active: 2022-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12579456 - Cognitive platform for deriving effort metric for optimizing cognitive treatment (2026-03-17),

2. 12236005 - Cognitive platform including computerized elements (2025-02-25),

3. 12220242 - Cognitive platform configured as a biomarker or other type of marker (2025-02-11),

4. 12138069 - Platform for identification of biomarkers using navigation tasks and treatments using navigation tasks (2024-11-12),

5. 12026636 - Cognitive platform for deriving effort metric for optimizing cognitive treatment (2024-07-02),

6. 12016700 - Cognitive platform coupled with a physiological component (2024-06-25),

7. 11846964 - Cognitive platform including computerized elements (2023-12-19),

8. 11839472 - Platforms to implement signal detection metrics in adaptive response-deadline procedures (2023-12-12),

9. 11723598 - Cognitive platform coupled with a physiological component (2023-08-15),

10. 11690560 - Cognitive platform configured as a biomarker or other type of marker (2023-07-04),

11. 11507178 - Cognitive platform including computerized elements (2022-11-22),

12. 11422919 - Systems and methods for scientific evaluation of program code outputs (2022-08-23),

13. 11304657 - Cognitive platform coupled with a physiological component (2022-04-19),

Title: The Innovative Mind of Titiimaea Alailima

Introduction

Titiimaea Alailima is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of cognitive technology, holding a total of 13 patents. His work focuses on enhancing cognitive skills and understanding neurodegenerative conditions through innovative platforms.

Latest Patents

Alailima's latest patents include a cognitive platform that incorporates computerized elements. This platform provides apparatus, systems, and methods for generating a quantified indicator of cognitive skills in individuals. In certain configurations, these systems can be implemented to enhance cognitive skills effectively. Another notable patent involves a cognitive platform configured as a biomarker or other type of marker. This system utilizes data collected from individual responses to computerized tasks to derive performance metrics, indicating cognitive abilities and applying predictive models to identify potential neurodegenerative conditions.

Career Highlights

Titiimaea Alailima is currently associated with Akili Interactive Labs, Inc., where he continues to push the boundaries of cognitive technology. His innovative work has garnered attention in the tech community, and he is recognized for his contributions to improving cognitive health.

Collaborations

Alailima collaborates with talented individuals such as Jeffrey Bower and Matthew Omernick, who share his vision of advancing cognitive technology.

Conclusion

Titiimaea Alailima's work exemplifies the intersection of technology and cognitive science. His innovative patents and contributions to Akili Interactive Labs, Inc. highlight his commitment to enhancing cognitive abilities and understanding neurodegenerative conditions. His ongoing efforts continue to inspire advancements in the field.

Profile summary based on public USPTO records.